Evidence map›Paper›PMID 22197371›Full record

ArticleJournal of molecular biology2012

Ligand binding and membrane insertion compete with oligomerization of the BclXL apoptotic repressor.

Vikas Bhat, Caleb B McDonald, David C Mikles, Brian J Deegan, Kenneth L Seldeen, Margaret L Bates, Amjad Farooq

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Conformation of BCL-XL upon Membrane Integration.Journal of molecular biology · 2015
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. When detergent meets bilayer: birth and coming of age of lipid bicelles.Progress in nuclear magnetic resonance spectroscopy · 2013
    Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vikas BhatDepartment of Biochemistry and Molecular Biology and USylvester Braman Family Breast Cancer Institute, Leonard Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Caleb B McDonald
David C Mikles
Brian J Deegan
Kenneth L Seldeen
Margaret L Bates
Amjad Farooq
University of Miami · US

Funding

Structural and Functional Studies of the Novel DBD Domain of MKP5R01GM083897 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FAROOQ, AMJAD · 2008 to 2012
$1.6M
Training in Translational Breast Cancer ResearchT32CA119929 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SLINGERLAND, JOYCE MARIE · 2007 to 2011
$1.4M
NCI NIH HHS T32 CA119929NCI NIH HHS T32-CA119929NIGMS NIH HHS R01 GM083897NIGMS NIH HHS R01-GM083897
6 · The paper itself

Abstract

B-cell lymphoma extra large (BclXL) apoptotic repressor plays a central role in determining the fate of cells to live or die during physiological processes such as embryonic development and tissue homeostasis. Herein, using a myriad of biophysical techniques, we provide evidence that ligand binding and membrane insertion compete with oligomerization of BclXL in solution. Of particular importance is the observation that such oligomerization is driven by the intermolecular binding of its C-terminal transmembrane (TM) domain to the canonical hydrophobic groove in a domain-swapped trans fashion, whereby the TM domain of one monomer occupies the canonical hydrophobic groove within the other monomer and vice versa. Binding of BH3 ligands to the canonical hydrophobic groove displaces the TM domain in a competitive manner, allowing BclXL to dissociate into monomers upon hetero-association. Remarkably, spontaneous insertion of BclXL into DMPC/DHPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine/1,2-dihexanoyl-sn-glycero-3-phosphocholine) bicelles results in a dramatic conformational change such that it can no longer recognize the BH3 ligands in what has come to be known as the "hit-and-run" mechanism. Collectively, our data suggest that oligomerization of a key apoptotic repressor serves as an allosteric switch that fine-tunes its ligand binding and membrane insertion pertinent to the regulation of apoptotic machinery.

Indexed as

Amino Acid Sequencebcl-X ProteinBinding, CompetitiveCell MembraneHumansLigandsMembrane ProteinsModels, MolecularMolecular Dynamics SimulationMolecular Sequence DataProtein BindingProtein ConformationProtein Interaction Domains and MotifsThermodynamicsBCL2L1 protein, humanbcl-X ProteinLigandsMembrane Proteins

Identifiers

PMID22197371
PMCPMC3268818
OpenAlexW2104181771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.